← Browse by Condition
Medical Condition

osteosarcoma

Total Trials
5
Recruiting Now
5
Trial Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 1
NCT06645808 EARLY_Phase 1
Recruiting

PET-imaging of Two Vartumabs in Patients With Solid Tumors

Enrollment
32 pts
Location
Netherlands
Sponsor
Var2 Pharmaceuticals
View Trial →
NCT05062707
Recruiting

Early Ageing During Therapy in AYA Cancer Patients

Enrollment
120 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT06541262 Phase 1, Phase 2
Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Enrollment
104 pts
Location
United States, Canad...
Sponsor
Milton S. Hershey Medical Cent...
View Trial →
NCT04282044 Phase 1
Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Enrollment
60 pts
Location
United States
Sponsor
BioEclipse Therapeutics
View Trial →
NCT07479732 Phase 1, Phase 2
Recruiting

Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Enrollment
56 pts
Location
China
Sponsor
Peking University People's Hos...
View Trial →